Cell Surface Markers Market size is set to grow by USD 14.07 billion from 2024-2028, COVID-19 pandemic impact to boost the market growth, Technavio

NEW YORK, July 31, 2024 /PRNewswire/ -- The global cell surface markers market size is estimated to grow by USD 14.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.25% during the forecast period. COVID-19 pandemic impact is driving market growth, with a trend towards increased use of diagnostics in cancer detection. However, high cost of instruments related to cell surface markers poses a challenge. Key market players include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA.

Get a detailed analysis on regions, market segments, customer landscape, and companies - Click for the snapshot of this report

Key Market Trends Fueling Growth

The cell surface markers market is experiencing growth due to their application in diagnostic methods for detecting cancer cells. With an estimated 19.3 million new cancer cases and 10 million cancer deaths reported in 2020, according to Globocan 2020, the demand for biomarkers is expected to rise. Cell surface markers function as identifiers for specific cell types by attaching to proteins on their surface. This identification process is crucial for cancer diagnosis, targeted therapy, drug research, and other applications. As a result, the global cell surface marker market is projected to expand significantly throughout the forecast period. 

The Cell Surface Markers market is witnessing significant growth due to increasing research activities in the fields of Mice and Rats for understanding Host-Pathogen interactions and inflammatory diseases. Antibodies are key players in identifying specific cell types and populations, driving demand in research applications and clinical diagnostics. In vitro diagnostics firms like Sysmex Europe SE and Diatron are investing in advanced technologies like the Aquarius 3 for high-content screening. Funding from financial markets and economic growth in the pharmaceutical industry are boosting drug development. Journal Molecular and Cellular Pathology and Journal Biomedicines publish research on cell surface antigens and proteins as identification tags for therapeutic targeting and personalized medicine. Signaling heterogeneity and organelle targets are emerging trends. Immune responses and disease severity are crucial factors influencing market growth. Cell analysis techniques are expanding applications in medical research and clinical diagnostics. 

Discover 360° analysis of this market. For complete information, schedule your consultation- Book Here!

Market Challenges

• Clinical laboratories and hospitals face operational sustainability concerns, making them cautious about investing in expensive cell surface marker analysis instruments. The high cost of sophisticated devices like flow cytometers and hematology analyzers, coupled with regulatory and reimbursement uncertainties, limit the entry of small clinical laboratories and hospitals into this market. Small pharmaceutical companies also hesitate to invest due to unclear cost-benefit ratios, as drug development expenses are already substantial. This reluctance from small players hampers the growth of the global cell surface markers market during the forecast period.
• The Cell Surface Markers Market faces challenges in various sectors including oncology, immunology, stem cell research, and infectious diseases. The market requires advanced cell analysis instruments like flow cytometers and hematology analyzers for research in these areas. Technological advancements, such as high-speed multiparametric analysis and development of multiplexed analysis platforms, are crucial for progress. Pharmaceutical industries and healthcare infrastructure invest heavily in research drug discovery, utilizing flow cytometry for detection and labeling in cancer, autoimmune disorders, and hematological disorders. Precision medicine and personalized therapies are driving market growth. However, intense competition among established players and emerging companies, favorable government initiatives, supportive reimbursement policies, and a robust regulatory framework are essential for market success. The market is highly fragmented, with a focus on chronic diseases like cardiovascular diseases. Collaborations and product portfolios are key market positioning strategies. Reagents and kits are essential for research, while advanced technologies and prevalence of cancer further fuel market demand.

For more insights on driver and challenges - Download a Sample Report

Segment Overview 

This cell surface markers market report extensively covers market segmentation by

1. Application 
• 1.1 Disease diagnosis
• 1.2 Research
• 1.3 drug discovery
2. Product 
• 2.1 Antibody
• 2.2 PCR array
3. Geography 
• 3.1 North America
• 3.2 Europe
• 3.3 Asia
• 3.4 Rest of World (ROW)

1.1 Disease diagnosis- Cell surface markers, also known as cell surface proteins, play a crucial role in identifying and classifying various cells due to their specific biological functions. In immunology, these markers are essential for efficient disease diagnosis, sample preparation, drug discovery, and treatment determination through immunophenotyping. The increasing adoption of in-vitro diagnostics (IVD) is driving market growth. IVD includes diagnostic test products, instruments, and supplies, which focus on identifying conditions outside the body with ease and speed. The rising prevalence of chronic diseases, such as cancer and cardiovascular disease, and the need for accurate and early disease detection have boosted the demand for IVDs. Advanced flow cytometers and high-quality antibodies facilitate rapid disease diagnosis and efficient drug discovery, fueling the growth of the global cell surface markers market in the disease diagnosis segment.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 - 2022) - Download a Sample Report

Research Analysis

Cell surface markers, also known as cell surface antigens, are proteins and molecules that act as identification tags on the exterior of cells. In the life sciences, they play a crucial role in medical research, diagnostics, and drug development. These markers are essential for the identification and differentiation of various cell types, including those involved in host-pathogen interactions, inflammatory diseases, and cancer. In research applications, they are used extensively in life sciences solutions, laboratories, and in vitro diagnostics. The prevalence of cancer and other diseases has led to an increased focus on cell surface markers in medical research. Mice and rats are commonly used in studies due to their genetic similarities to humans. Antibodies are frequently used to detect and isolate cell surface markers, and funding for research in this area continues to grow. Overall, cell surface markers are invaluable tools in the field of life sciences, contributing to a better understanding of various diseases and potential therapeutic targets.

Market Research Overview

The Cell Surface Markers Market encompasses the use of cell surface antigens, proteins, and molecules as identification tags for specific cell types and populations in various fields of medical research. These markers play a crucial role in disease mechanisms, therapeutic targeting, and personalized medicine. Applications span across oncology, immunology, stem cell research, and infectious diseases. Cell analysis techniques, such as flow cytometry and hematology analyzers, are expanding in applications, driven by technological advancements and the development of multiplexed analysis platforms. Pharmaceutical industries and clinical diagnostics utilize these tools for research drug discovery, detection and labeling, and monitoring of diseases. The market is highly fragmented, with intense competition among established players and emerging companies. Favorable government initiatives, supportive reimbursement policies, and a robust regulatory framework foster market growth. Applications extend to chronic diseases like cancer, cardiovascular diseases, and autoimmune disorders. The market's size is influenced by the prevalence of diseases, economic factors, and the financial markets. Publications in journals like Molecular Cellular Pathology, Journal Biomedicines, and High-content screening provide insights into the latest research and developments. The market also includes the use of animals like Mice and Rats, antibodies, research applications, clinical applications, laboratories, in vitro diagnostics, funding, host-pathogen interactions, inflammatory diseases, organelle targets, signaling heterogeneity, economy, drugs, firms, and financial markets.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Application
• Disease Diagnosis
• Research
• Drug Discovery
• Product
• Antibody
• PCR Array
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED